ENTERO

Entero Healthcare Solutions Share Price

 

 

Invest in Entero Healthcare Solutions with 2.65X leverage

Invest with MTF
Entero Healthcare Solutions live price: ₹1192.4. It opened at ₹1,240 vs previous close ₹1,234; intraday high/low: ₹1,240/₹1,185. The 50 & 200 DMA stand at ₹1,121.43/₹1,138.42.

Entero Healthcare Solutions Performance

  • Today's Low
  • ₹1,185
  • Today's High
  • ₹1,240
  • 52 Week Low
  • ₹944
  • 52 Week High
  • ₹1,511
  • Open Price₹1,240
  • Previous Close₹1,234
  • Volume46,042
  • 50 DMA₹1,121.43
  • 100 DMA₹1,116.20
  • 200 DMA₹1,138.42

Investment Returns

  • Over 1 Month + 14.14%
  • Over 3 Month + 0.07%
  • Over 6 Month + 11.7%
  • Over 1 Year + 0.33%

Smart Investing Starts Here Start SIP with Entero Healthcare Solutions for Steady Growth!

Invest Now

Entero Healthcare Solutions Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 46
  • PEG Ratio
  • 1.8
  • Market Cap Cr
  • 5,188
  • P/B Ratio
  • 2.9
  • Average True Range
  • 50.94
  • EPS
  • 26.93
  • Dividend Yield
  • 0
  • MACD Signal
  • 28.16
  • RSI
  • 69.94
  • MFI
  • 81.81

Entero Healthcare Solutions Financials

Entero Healthcare Solutions Technicals

EMA & SMA

Current Price
₹1,192.40
-42 (-3.4%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹1,157.55
  • 50 Day
  • ₹1,121.43
  • 100 Day
  • ₹1,116.20
  • 200 Day
  • ₹1,138.42

Resistance and Support

1239.87 Pivot Speed
  • R3 1,289.33
  • R2 1,274.67
  • R1 1,254.53
  • S1 1,219.73
  • S2 1,205.07
  • S3 1,184.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Entero Healthcare Solutions is a leading supply chain and distribution company in India, specializing in pharmaceuticals, medical devices, and healthcare products. It provides end-to-end logistics services, connecting manufacturers with pharmacies, hospitals, and healthcare providers nationwide.

Entero Healthcare Solutions Ltd has an operating revenue of Rs. 6,020.34 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 10% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 16 indicates it belongs to a strong industry group of Medical-Supplies and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Entero Healthcare Solutions Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-12 Quarterly Results
2025-08-08 Quarterly Results
2025-05-27 Audited Results
2025-02-12 Quarterly Results

Entero Healthcare Solutions F&O

Entero Healthcare Solutions Shareholding Pattern

52.42%
10.25%
5.14%
11.57%
20.62%

Entero Healthcare Solutions FAQs

Entero Healthcare Solutions share price is ₹1,192 As on 07 April, 2026 | 12:07

The Market Cap of Entero Healthcare Solutions is ₹5188.2 Cr As on 07 April, 2026 | 12:07

The P/E ratio of Entero Healthcare Solutions is 46 As on 07 April, 2026 | 12:07

The PB ratio of Entero Healthcare Solutions is 2.9 As on 07 April, 2026 | 12:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23